Exicure (XCUR) Share-based Compensation Growth (3y) (2019 - 2025)
Exicure (XCUR) Share-based Compensation Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
4.80% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-83.63% |
| Jun 30, 2025 |
-87.46% |
| Dec 31, 2024 |
-80.17% |
| Sep 30, 2024 |
-82.22% |
| Jun 30, 2024 |
-80.12% |
| Mar 31, 2024 |
-78.69% |
| Dec 31, 2023 |
-66.94% |
| Sep 30, 2023 |
-56.75% |
| Jun 30, 2023 |
21.22% |
| Mar 31, 2023 |
-11.28% |
| Dec 31, 2022 |
-17.16% |
| Sep 30, 2022 |
-17.02% |
| Jun 30, 2022 |
4.92% |
| Mar 31, 2022 |
-11.24% |
| Dec 31, 2021 |
14.75% |
| Sep 30, 2021 |
19.88% |
| Jun 30, 2021 |
22.17% |
| Mar 31, 2021 |
12.31% |
| Dec 31, 2020 |
17.52% |
| Jun 30, 2020 |
14.54% |
